Immunovant Inc. (IMVT)
14.39
-1.39 (-8.81%)
At close: Apr 04, 2025, 11:54 AM
Immunovant Revenue
Immunovant reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending December 31, 2024, Immunovant generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
207
Market Cap
2.44B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Mar 31, 2024 | 0 | n/a |
| Mar 31, 2023 | 0 | n/a |
| Mar 31, 2022 | 0 | n/a |
| Mar 31, 2021 | 0 | n/a |
| Mar 31, 2020 | 0 | n/a |